Product Images Naloxone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Naloxone Hydrochloride NDC 76045-112 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fresenius Kabi Logo - nal01 0006 01

Fresenius Kabi Logo - nal01 0006 01

Structural Formula - nal01 0006 02

Structural Formula - nal01 0006 02

Not available.*

Figure 1 - nal01 0006 03

Figure 1 - nal01 0006 03

This text contains limited information related to a medical device. It mentions a "Plunger Rod," "Syringe Barrel," and "Syringe Tip Cap." The label states not to remove it. It seems like a component list or instructions related to assembling a syringe.*

Figure 2 - nal01 0006 04

Figure 2 - nal01 0006 04

Figure 3 - nal01 0006 05

Figure 3 - nal01 0006 05

Fresenius Kabi Logo - nal01 0006 06

Fresenius Kabi Logo - nal01 0006 06

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Syringe Label - nal01 0006 07

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Syringe Label - nal01 0006 07

This is a 1mL single-dose prescription-only solution from Fresenius Kabi containing HCl Injection with a concentration of mg/mL, suitable for IV, IM, or Subcutaneous use. The product code is N(01)00376045114010.*

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Print Mat Label - nal01 0006 08

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Print Mat Label - nal01 0006 08

This text appears to be a description of a medication in a prefilled syringe. The medication is stored at a temperature between 20-25°C and needs to be protected from light. The dosage information is available in the package insert. It is important not to place the syringe on a sterile field. Unused portions should be discarded.*

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Shelf Carton Panel - nal01 0006 09

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 1 mL Shelf Carton Panel - nal01 0006 09

Naloxone Hydrochloride Injection, USP is manufactured for intravenous, intramuscular, or subcutaneous use. Each mL contains 0.4 mg of naloxone hydrochloride, USP, and 9 mg of sodium chloride. It is adjusted with hydrochloric acid to meet USP limits. The usual dosage can be found in the package insert. Remember to store at 20°C to 25°C and protect from light. Avoid placing the syringe on the sterile field. Naloxone comes in a concentration of 0.4 mg/mL.*

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Syringe Label - nal01 0006 10

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Syringe Label - nal01 0006 10

This is a 2ml Single-Dose injection by Fresenius Kabi, intended for intravenous (IV), intramuscular (IM), or subcutaneous use. The medication contains 1 mg/mL of HCl. The product code is N(01)00376045112016.*

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Print Mat Label - nal01 0006 11

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Print Mat Label - nal01 0006 11

Description: This text includes information about Naloxone, a medication in the form of a 2mg/2mL single-dose prefilled syringe. It is a Hydrochloride Injection for intravenous, intramuscular, or subcutaneous use. The storage instructions advise keeping it at 20°C to 5°C and protect it from light. The text also mentions to read the instructions, provide the usual dosage from the package insert, and not to place the syringe in a sharps container. The text indicates it is produced by Fresenius Kabi.*

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Shelf Carton Panel - nal01 0006 12

PACKAGE LABEL - PRINCIPAL DISPLAY – Naloxone 2 mL Shelf Carton Panel - nal01 0006 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.